Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 805 to 810 of 810 entries
Sorted by: Best Match Show Resources per page
Impact of oral soluble guanylate cyclase stimulators in heart failure: A systematic review and Meta-analysis of randomized controlled trials.

American heart journal

Moghaddam N, Malhi N, Toma M.
PMID: 34283990
Am Heart J. 2021 Nov;241:74-82. doi: 10.1016/j.ahj.2021.07.003. Epub 2021 Jul 18.

BACKGROUND: Soluble guanylate cyclase (sGC) stimulators are a novel class of medications with emerging role in heart failure (HF). The aim of this study is to evaluate the efficacy and safety of oral sGC stimulators in patients with HF...

Cite
Moghaddam N, Malhi N, Toma M. Impact of oral soluble guanylate cyclase stimulators in heart failure: A systematic review and Meta-analysis of randomized controlled trials. Am Heart J. 2021;241:74-82doi: 10.1016/j.ahj.2021.07.003.
Moghaddam, N., Malhi, N., & Toma, M. (2021). Impact of oral soluble guanylate cyclase stimulators in heart failure: A systematic review and Meta-analysis of randomized controlled trials. American heart journal, 24174-82. https://doi.org/10.1016/j.ahj.2021.07.003
Moghaddam, Nima, et al. "Impact of oral soluble guanylate cyclase stimulators in heart failure: A systematic review and Meta-analysis of randomized controlled trials." American heart journal vol. 241 (2021): 74-82. doi: https://doi.org/10.1016/j.ahj.2021.07.003
Moghaddam N, Malhi N, Toma M. Impact of oral soluble guanylate cyclase stimulators in heart failure: A systematic review and Meta-analysis of randomized controlled trials. Am Heart J. 2021 Nov;241:74-82. doi: 10.1016/j.ahj.2021.07.003. Epub 2021 Jul 18. PMID: 34283990.
Copy Download .nbib Format: NLM
Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review.

Journal of the American Heart Association

Fazelpour S, Sadek MM, Nery PB, Beanlands RS, Tzemos N, Toma M, Birnie DH.
PMID: 34472360
J Am Heart Assoc. 2021 Sep 07;10(17):e021183. doi: 10.1161/JAHA.121.021183. Epub 2021 Sep 02.

Background Corticosteroid therapy for the treatment of clinically manifest cardiac sarcoidosis is generally recommended. Our group previously systematically reviewed the data in 2013; since then, there has been increasing quality and quantity of data and also interest in nonsteroid...

Cite
Fazelpour S, Sadek MM, Nery PB, et al. Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review. J Am Heart Assoc. 2021;10(17):e021183doi: 10.1161/JAHA.121.021183.
Fazelpour, S., Sadek, M. M., Nery, P. B., Beanlands, R. S., Tzemos, N., Toma, M., & Birnie, D. H. (2021). Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review. Journal of the American Heart Association, 10(17), e021183. https://doi.org/10.1161/JAHA.121.021183
Fazelpour, Siavosh, et al. "Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review." Journal of the American Heart Association vol. 10,17 (2021): e021183. doi: https://doi.org/10.1161/JAHA.121.021183
Fazelpour S, Sadek MM, Nery PB, Beanlands RS, Tzemos N, Toma M, Birnie DH. Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review. J Am Heart Assoc. 2021 Sep 07;10(17):e021183. doi: 10.1161/JAHA.121.021183. Epub 2021 Sep 02. PMID: 34472360.
Copy Download .nbib Format: NLM
RNA sequencing of blood in coronary artery disease: involvement of regulatory T cell imbalance.

BMC medical genomics

McCaffrey TA, Toma I, Yang Z, Katz R, Reiner J, Mazhari R, Shah P, Tackett M, Jones D, Jepson T, Falk Z, Wargodsky R, Shtakalo D, Antonets D, Ertle J, Kim JH, Lai Y, Arslan Z, Aledort E, Alfaraidy M, Laurent GS.
PMID: 34479557
BMC Med Genomics. 2021 Sep 03;14(1):216. doi: 10.1186/s12920-021-01062-2.

BACKGROUND: Cardiovascular disease had a global prevalence of 523 million cases and 18.6 million deaths in 2019. The current standard for diagnosing coronary artery disease (CAD) is coronary angiography. Surprisingly, despite well-established clinical indications, up to 40% of the...

Cite
McCaffrey TA, Toma I, Yang Z, et al. RNA sequencing of blood in coronary artery disease: involvement of regulatory T cell imbalance. BMC Med Genomics. 2021;14(1):216doi: 10.1186/s12920-021-01062-2.
McCaffrey, T. A., Toma, I., Yang, Z., Katz, R., Reiner, J., Mazhari, R., Shah, P., Tackett, M., Jones, D., Jepson, T., Falk, Z., Wargodsky, R., Shtakalo, D., Antonets, D., Ertle, J., Kim, J. H., Lai, Y., Arslan, Z., Aledort, E., Alfaraidy, M., & Laurent, G. S. (2021). RNA sequencing of blood in coronary artery disease: involvement of regulatory T cell imbalance. BMC medical genomics, 14(1), 216. https://doi.org/10.1186/s12920-021-01062-2
McCaffrey, Timothy A, et al. "RNA sequencing of blood in coronary artery disease: involvement of regulatory T cell imbalance." BMC medical genomics vol. 14,1 (2021): 216. doi: https://doi.org/10.1186/s12920-021-01062-2
McCaffrey TA, Toma I, Yang Z, Katz R, Reiner J, Mazhari R, Shah P, Tackett M, Jones D, Jepson T, Falk Z, Wargodsky R, Shtakalo D, Antonets D, Ertle J, Kim JH, Lai Y, Arslan Z, Aledort E, Alfaraidy M, Laurent GS. RNA sequencing of blood in coronary artery disease: involvement of regulatory T cell imbalance. BMC Med Genomics. 2021 Sep 03;14(1):216. doi: 10.1186/s12920-021-01062-2. PMID: 34479557; PMCID: PMC8414682.
Copy Download .nbib Format: NLM
Impact of General Anesthesia Guided by State Entropy (SE) and Response Entropy (RE) on Perioperative Stability in Elective Laparoscopic Cholecystectomy Patients-A Prospective Observational Randomized Monocentric Study.

Entropy (Basel, Switzerland)

Dinu AR, Rogobete AF, Popovici SE, Bedreag OH, Papurica M, Dumbuleu CM, Velovan RR, Toma D, Georgescu CM, Trache LI, Barsac C, Luca L, Buzzi B, Maghiar A, Sandesc MA, Rimawi S, Vaduva MM, Bratu LM, Luminosu PM, Sandesc D.
PMID: 33286130
Entropy (Basel). 2020 Mar 19;22(3). doi: 10.3390/e22030356.

Laparoscopic cholecystectomy is one of the most frequently performed interventions in general surgery departments. Some of the most important aims in achieving perioperative stability in these patients is diminishing the impact of general anesthesia on the hemodynamic stability and...

Cite
Dinu AR, Rogobete AF, Popovici SE, et al. Impact of General Anesthesia Guided by State Entropy (SE) and Response Entropy (RE) on Perioperative Stability in Elective Laparoscopic Cholecystectomy Patients-A Prospective Observational Randomized Monocentric Study. Entropy (Basel). 2020;22(3)doi: 10.3390/e22030356.
Dinu, A. R., Rogobete, A. F., Popovici, S. E., Bedreag, O. H., Papurica, M., Dumbuleu, C. M., Velovan, R. R., Toma, D., Georgescu, C. M., Trache, L. I., Barsac, C., Luca, L., Buzzi, B., Maghiar, A., Sandesc, M. A., Rimawi, S., Vaduva, M. M., Bratu, L. M., Luminosu, P. M., & Sandesc, D. (2020). Impact of General Anesthesia Guided by State Entropy (SE) and Response Entropy (RE) on Perioperative Stability in Elective Laparoscopic Cholecystectomy Patients-A Prospective Observational Randomized Monocentric Study. Entropy (Basel, Switzerland), 22(3), . https://doi.org/10.3390/e22030356
Dinu, Anca Raluca, et al. "Impact of General Anesthesia Guided by State Entropy (SE) and Response Entropy (RE) on Perioperative Stability in Elective Laparoscopic Cholecystectomy Patients-A Prospective Observational Randomized Monocentric Study." Entropy (Basel, Switzerland) vol. 22,3 (2020). doi: https://doi.org/10.3390/e22030356
Dinu AR, Rogobete AF, Popovici SE, Bedreag OH, Papurica M, Dumbuleu CM, Velovan RR, Toma D, Georgescu CM, Trache LI, Barsac C, Luca L, Buzzi B, Maghiar A, Sandesc MA, Rimawi S, Vaduva MM, Bratu LM, Luminosu PM, Sandesc D. Impact of General Anesthesia Guided by State Entropy (SE) and Response Entropy (RE) on Perioperative Stability in Elective Laparoscopic Cholecystectomy Patients-A Prospective Observational Randomized Monocentric Study. Entropy (Basel). 2020 Mar 19;22(3). doi: 10.3390/e22030356. PMID: 33286130; PMCID: PMC7516829.
Copy Download .nbib Format: NLM
A Case of Repeated Necrotizing Lymphadenitis with MEFV Gene Mutations.

Internal medicine (Tokyo, Japan)

Yamamura Y, Furuichi K, Toyama T, Oshima M, Ogura H, Sato K, Nakagawa S, Miyagawa T, Kitajima S, Hara A, Iwata Y, Sakai N, Shimizu M, Ikeda H, Toma T, Takasawa K, Yachie A, Wada T.
PMID: 34511567
Intern Med. 2021 Sep 11; doi: 10.2169/internalmedicine.7882-21. Epub 2021 Sep 11.

We herein report a 36-year-old man with repeated necrotizing lymphadenitis due to MEFV gene mutations. The patient's chief complaints were a fever and painful cervical lymphadenopathy. We diagnosed him with necrotizing lymphadenitis based on the pathological findings of the...

Cite
Yamamura Y, Furuichi K, Toyama T, et al. A Case of Repeated Necrotizing Lymphadenitis with MEFV Gene Mutations. Intern Med. 2021;doi: 10.2169/internalmedicine.7882-21.
Yamamura, Y., Furuichi, K., Toyama, T., Oshima, M., Ogura, H., Sato, K., Nakagawa, S., Miyagawa, T., Kitajima, S., Hara, A., Iwata, Y., Sakai, N., Shimizu, M., Ikeda, H., Toma, T., Takasawa, K., Yachie, A., & Wada, T. (2021). A Case of Repeated Necrotizing Lymphadenitis with MEFV Gene Mutations. Internal medicine (Tokyo, Japan), . https://doi.org/10.2169/internalmedicine.7882-21
Yamamura, Yuta, et al. "A Case of Repeated Necrotizing Lymphadenitis with MEFV Gene Mutations." Internal medicine (Tokyo, Japan) vol. (2021). doi: https://doi.org/10.2169/internalmedicine.7882-21
Yamamura Y, Furuichi K, Toyama T, Oshima M, Ogura H, Sato K, Nakagawa S, Miyagawa T, Kitajima S, Hara A, Iwata Y, Sakai N, Shimizu M, Ikeda H, Toma T, Takasawa K, Yachie A, Wada T. A Case of Repeated Necrotizing Lymphadenitis with MEFV Gene Mutations. Intern Med. 2021 Sep 11; doi: 10.2169/internalmedicine.7882-21. Epub 2021 Sep 11. PMID: 34511567.
Copy Download .nbib Format: NLM
Incidence and risk factors of acute encephalopathy with biphasic seizures in febrile status epilepticus.

Brain & development

Ichinose F, Nakamura T, Kira R, Furuno K, Ishii S, Takamura K, Hashiguchi M, Inoue T, Senju A, Ichimiya Y, Sakakibara T, Sugiyama N, Naitou T, Higuchi N, Togawa M, Torii KI, Toda S, Iwamatsu H, Sato T, Tsurui S, Tanaka H, Motobayashi M, Abe A, Kawaguchi A, Matsuo M.
PMID: 34362595
Brain Dev. 2022 Jan;44(1):36-43. doi: 10.1016/j.braindev.2021.07.004. Epub 2021 Aug 03.

OBJECTIVE: To clarify the incidence and risk factors of acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) in pediatric patients with febrile status epilepticus (FSE).METHODS: We retrospectively surveyed patients with FSE (≥20 min and ≥40 min) who...

Cite
Ichinose F, Nakamura T, Kira R, et al. Incidence and risk factors of acute encephalopathy with biphasic seizures in febrile status epilepticus. Brain Dev. 2021;44(1):36-43doi: 10.1016/j.braindev.2021.07.004.
Ichinose, F., Nakamura, T., Kira, R., Furuno, K., Ishii, S., Takamura, K., Hashiguchi, M., Inoue, T., Senju, A., Ichimiya, Y., Sakakibara, T., Sugiyama, N., Naitou, T., Higuchi, N., Togawa, M., Torii, K. I., Toda, S., Iwamatsu, H., Sato, T., Tsurui, S., Tanaka, H., Motobayashi, M., Abe, A., Kawaguchi, A., & Matsuo, M. (2022). Incidence and risk factors of acute encephalopathy with biphasic seizures in febrile status epilepticus. Brain & development, 44(1), 36-43. https://doi.org/10.1016/j.braindev.2021.07.004
Ichinose, Fumio, et al. "Incidence and risk factors of acute encephalopathy with biphasic seizures in febrile status epilepticus." Brain & development vol. 44,1 (2022): 36-43. doi: https://doi.org/10.1016/j.braindev.2021.07.004
Ichinose F, Nakamura T, Kira R, Furuno K, Ishii S, Takamura K, Hashiguchi M, Inoue T, Senju A, Ichimiya Y, Sakakibara T, Sugiyama N, Naitou T, Higuchi N, Togawa M, Torii KI, Toda S, Iwamatsu H, Sato T, Tsurui S, Tanaka H, Motobayashi M, Abe A, Kawaguchi A, Matsuo M. Incidence and risk factors of acute encephalopathy with biphasic seizures in febrile status epilepticus. Brain Dev. 2022 Jan;44(1):36-43. doi: 10.1016/j.braindev.2021.07.004. Epub 2021 Aug 03. PMID: 34362595.
Copy Download .nbib Format: NLM
Showing 805 to 810 of 810 entries